$55.78
0.01 (+0.02%)
Novartis AG (ADR) (NVS)
CAPS Rating:
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
Fool.com
Investment advice you can actually understand
RSS Headlines
Fool UK
Recs
Defensive LT play in tumultuous times. Has weathered the storm to date very nicely. Solid margins and revenue growth over the years and well into the current economic crisis. Plus a decent dividend. Can't ask for much more nowadays.